Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Intrexon Corp (XON)

17.94 -0.14 (-0.77%)

04-20 16:01

Open:

18.12

Pre. Close:

18.08

High:

18.29

Low:

17.831

Volume:

3,058,992

Market Cap:

2315M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.31 - 18.459

18.459 - 18.559

Low:

17.521 - 17.685

17.685 - 17.796

Close:

17.725 - 17.979

17.979 - 18.15

Technical analysis  (as of: 2018-04-20 4:35:00 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 23.55     One year: 27.50

Support:

Support1: 16.91    Support2: 14.90

Resistance:

Resistance1: 20.16    Resistance2: 23.55

Pivot:

17.97

Moving Averages:

MA(5): 18.58     MA(20): 17.46

MA(100): 14.44     MA(250): 17.85

MACD:

MACD(12,26): 0.83     Signal(12,26,9): 0.87

%K %D:

%K(14,3): 64.58     %D(3): 71.34

RSI:

RSI(14): 54.72

52-Week:

High: 26.99  Low: 10.26  Change(%): -11.5

Average Vol(K):

3-Month: 154492  10-Days 148824

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
XON has closed above bottom band by 49.4%. Bollinger Bands are 64.8% wider than normal. The large width of the bands suggest high volatility as compared to XON's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

2018-04-16T07:00:00-04:00
Exemplar Genetics Rare Neurological Disease Model Cleared by FDA for Commercial Research Use

2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned

2018-04-09T11:28:35-04:00
2 Biotech Stocks Whose Rallies Should Continue

2018-04-09T07:19:12-04:00
Novartis takeout of AveXis stokes buying in gene therapy players

2018-03-31T14:18:54-04:00
Your Daily Pharma Scoop: Galectin Updates Investors, Pfizer's Tafamidis, Solid Biosciences' DMD Candidate

2018-03-29T12:14:26-04:00
Intrexon on go to start clinical study of novel approach to treat type 1 diabetes

2018-03-29T09:26:00-04:00
ActoBio Therapeutics Greenlighted by FDA to Commence a Phase Ib/IIa Trial with AG019 for the Treatment of Early Onset Type 1 Diabetes

2018-03-13T09:00:00-04:00
Newman Ferrara LLP Announces Corporate Governance Investigation of Intrexon Corporation - XON

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

129.07

Shares Float (M)

127.72

% Held by Insiders

% Held by Institutions

77.00

Shares Short (K)

24828

Shares Short Prior Month (K)

19530

Stock Financials

EPS

-0.790

EPS Est. Current Year

-0.870

EPS Est. Next Year

-0.700

EPS Est. Next Quarter

-0.210

Forward EPS

-0.550

Book Value (p.s.)

4.810

PEG Ratio

0.51

Profit Margin

-53.13

Operating Margin

-53.12

Return on Assets (ttm)

-13.0

Return on Equity (ttm)

-21.4

Qtrly Rev. Growth

67.4

Gross Profit (p.s.)

0.825

Sales Per Share

EBITDA (p.s.)

-0.555

Qtrly Earnings Growth

Operating Cash Flow (M)

-104.14

Levered Free Cash Flow (M)

-64.48

atoplab.com

Valuation

P/E

-22.71

P/E Growth Ratio

-0.01

P/BV

3.73

P/S

1205997824.00

P/CF

-22.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2015-06-12

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.